Author/Authors :
Tabatabaiefar, MA Cellular and Molecular Research Center - School of Medicine - Shahrekord University of Medical Sciences, Shahrekord, Iran , Montazer Zohour, M Cellular and Molecular Research Center - School of Medicine - Shahrekord University of Medical Sciences, Shahrekord, Iran , Shariati, L Cellular and Molecular Research Center - School of Medicine - Shahrekord University of Medical Sciences, Shahrekord, Iran , Farrokhi, E Cellular and Molecular Research Center - School of Medicine - Shahrekord University of Medical Sciences, Shahrekord, Iran , Hashemzadeh Chaleshtori, M Cellular and Molecular Research Center - School of Medicine - Shahrekord University of Medical Sciences, Shahrekord, Iran , Alasti, F Dept. of Medical Genetics - University of Antwerp, Antwerp, Belgium , Camp, GV Dept. of Medical Genetics - University of Antwerp, Antwerp, Belgium , Farhud, DD School of Public Health - Tehran University of Medical Sciences, Tehran , Noori-Daloii, MR Dept. of Medical Genetics - School of Medicine - Tehran University of Medical Sciences, Tehran
Abstract :
Background: Hearing loss (HL) is the most frequent sensory birth defect in humans. Autosomal recessive non-syndromic
HL (ARNSHL) is the most common type of hereditary HL. It is extremely heterogeneous and over 70 loci (known as
DFNB) have been identified. This study was launched to determine the relative contribution of more frequent loci in a
cohort of ARNSHL families.
Methods: Thirty-seven Iranian families including 36 ARNSHL families and 1 family with Pendred syndrome each with
≥ 4 affected individuals, from seven provinces of Iran, were ascertained. DFNB1 contribution was initially studied by
DNA sequencing of GJB2 and linkage analysis using the relative STR markers. The excluded families were then subjected
to homozygositymapping for fifteen ARNSHL loci.
Results: Sixteen families were found to be linked to seven different known loci, including DFNB1 (6 families), DFNB4 (3
families +1 familywith Pendred syndrome), DFNB63 (2 families), DFNB2 (1 family), DFNB7/11 (1 family), DFNB9 (1 family)
and DFNB21 (1 family). DNA sequencing of the corresponding genes is in progress to identify the pathogenic mutations.
Conclusion: The genetic causes were clarified in 43.2% of the studied families, giving an overview of the causes of
ARNSHL in Iran. DFNB4 is ranked second after DFNB1 in the studied cohort. More genetic and epigenetic investigations
will have to be done to reveal the causes in the remaining families.
Keywords :
ARNSHL , Genetic linkage analysis , DFNB loci , Iran